Vera Therapeutics VERA
NASDAQ VERA
$30.42 -0.57 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vera Therapeutics (VERA) Cash & Equivalents (2020 - 2026)

Updated

Vera Therapeutics' Cash & Equivalents came in at $48.88 million for Q2 2026, down 0.5% from $49.12 million a year earlier and down 57.3% from the prior quarter.

Analysis

Vera Therapeutics (VERA) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Vera Therapeutics' Cash & Equivalents was $354.73 million, up 282.9% from FY2024.

  • Cash & Equivalents has increased in each of the last three years, with a five-year compound annual growth rate of 45.9% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $92.65 million in FY2024 (+102.8%), $45.68 million in FY2023 (+5.1%), $43.46 million in FY2022 (-45.5%) and $79.67 million in FY2021 (+48.5%).
  • The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q3 2024.
  • Year-over-year, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 84.9%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2025 (growth of 282.9%), and the weakest in Q3 2022 (a decline of 64.6%).
  • Business Quant data shows VERA's Cash & Equivalents at $114.35 million (Q1 2026), $354.73 million (Q4 2025) and $57.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Vera Therapeutics 2.23 Bn 2.23 Bn - 48.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.88 Mn
Mar 31, 2026 114.35 Mn
Dec 31, 2025 354.73 Mn
Sep 30, 2025 57.77 Mn
Jun 30, 2025 49.12 Mn
Mar 31, 2025 55.09 Mn
Dec 31, 2024 92.65 Mn
Sep 30, 2024 27.26 Mn
Jun 30, 2024 25.09 Mn
Mar 31, 2024 69.11 Mn
Dec 31, 2023 45.68 Mn
Sep 30, 2023 27.44 Mn
Jun 30, 2023 33.89 Mn
Mar 31, 2023 137.39 Mn
Dec 31, 2022 43.46 Mn
Sep 30, 2022 30.48 Mn
Jun 30, 2022 50.43 Mn
Mar 31, 2022 111.51 Mn
Dec 31, 2021 79.67 Mn
Sep 30, 2021 86.19 Mn
API Access

Vera Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VERA&period=max&api_key=YOUR_API_KEY